Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Mar 2023 for Biocryst Pharmaceuticals INC, €19k.
Filing timeline
BuySaleRobert Alexander Ingram
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Alexander Ingram: trading record in brief
Robert Alexander Ingram is a declared insider at 5 companies; the most frequent names are Biocryst Pharmaceuticals Inc, Black Diamond Therapeutics, Inc. and Novan, Inc. Between 31 December 2015 and 28 February 2023, the trades on record add up to 30 filings.
Purchases make up the whole of the open-market record (4 purchases, €377k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 26 share grants.
A typical purchase (the median) is worth €111k.
Most recently, on 2 March 2023, the filings show a share grant worth €19k in Biocryst Pharmaceuticals Inc. The last purchase on record was published on 1 October 2020, which is 2,213 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Alexander Ingram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
2,259 shares@ US$8.8513.4% of flowCommon StockSEC:0001127602-23-008391:0
9,375 shares@ US$1.5012.3% of flowCommon StockSEC:0001415889-22-012795:0
1,497 shares@ US$13.3613.8% of flowCommon StockSEC:0001127602-22-026823:0
6,584 shares@ US$2.6216.1% of flowCommon StockSEC:0001415889-22-009771:0
1,438 shares@ US$13.9014.1% of flowCommon StockSEC:0001127602-22-022009:0
8,498 shares@ US$2.0315.2% of flowCommon StockSEC:0001415889-22-006739:0
12,866 shares0Common StockSEC:0001127602-22-017165:0
2,078 shares@ US$9.3112.8% of flowCommon StockSEC:0001127602-22-016390:0
5,795 shares@ US$3.0214.7% of flowCommon StockSEC:0001415889-22-003184:0
1,128 shares@ US$16.6111.9% of flowCommon StockSEC:0001127602-22-007725:0
3,296 shares@ US$5.3114.4% of flowCommon StockSEC:0001415889-21-006070:0
1,554 shares@ US$12.0611.8% of flowCommon StockSEC:0001127602-21-030043:0
1,869 shares@ US$9.9014.6% of flowCommon StockSEC:0001415889-21-004540:0
1,177 shares@ US$15.9211.3% of flowCommon StockSEC:0001127602-21-024776:0
1,255 shares@ US$12.9512.7% of flowCommon StockSEC:0001104659-21-084242:0
1,188 shares@ US$15.7710.9% of flowCommon StockSEC:0001127602-21-018501:0
505 shares@ US$34.295.7% of flowCommon StockSEC:0000899243-20-034190:0
3,669 shares@ US$5.117.6% of flowCommon StockSEC:0001127602-20-030285:0
5,000 shares@ US$30.45751.6% of flowCommon StockSEC:0000899243-20-026660:0
Canonical exit: 29 Dec 2020 (T+90)
4,518 shares@ US$4.156.8% of flowCommon StockSEC:0001127602-20-024637:0
4,171 shares@ US$4.506.8% of flowCommon StockSEC:0001127602-20-018704:0
6,250 shares@ US$3.006.4% of flowCommon StockSEC:0001127602-20-009058:0
6,578 shares@ US$2.85Common StockSEC:0001127602-19-034162:0
20,000 shares@ US$1.45Common StockSEC:0001127602-19-033025:0
Canonical exit: 16 Feb 2020 (T+90)
6,270 shares@ US$2.99Common StockSEC:0001127602-19-027858:0
25 of 30 declarations
